BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 23, 2004
View Archived Issues
Canadian approval for Humira
Read More
Celgene and Galapagos sign up for target discovery collaboration
Read More
Medicure to develop MC-1/ARB combination product
Read More
New European study for TheraCIM in pancreatic cancer
Read More
AstraZeneca reconfirms safety of Crestor
Read More
Approval for Atrovent HFA
Read More
Positive opinion handed down for Prialt in Europe
Read More
Phase I studies completed for aerosolized hydroxychloroquine
Read More
European orphan drug designation for Aplidin for multiple myeloma
Read More
Morphochem and Probiodrug to develop DPP-IV inhibitors
Read More
Dyax and Epix form new peptide collaboration
Read More
CA4P enters phase II study
Read More
Improved antimicrobial activity of novel dihydrothiazine phenyloxazolidinones
Read More
Preclinical and clinical efficacy of dextofisopam reported for IBS and IBD
Read More
Preclinical efficacy of rosiglitazone in reducing cutaneous inflammation in psoriasis
Read More
Preclinical characterization and pharmacokinetics of a novel lincosamide VIC-5555
Read More
Novel 17beta-HSD inhibitors designed by Sterix
Read More
Preclinical characterization and pharmacokinetics of a novel peptide deformylase inhibitor, LBM-415
Read More
Cannabinoid CB2 receptor modulators described in a patent
Read More
IRM patents cathepsin D inhibitors for rheumatoid arthritis, osteoarthritis, inflammation, etc.
Read More
Merck presents series of sodium channel blockers
Read More
Dual acting piperidine derivatives claimed by AstraZeneca
Read More
Antitumor treatments described in patent literature
Read More
Cardioprotective effects of K+ channel blocker from Aventis
Read More
Selective nicotinic receptor partial agonist for the treatment of AD and schizophrenia
Read More
Direct positive inotropic action on cardiac myosin may improve therapy for congestive heart failure
Read More
Nicotinic receptor agonist shows procognitive activity
Read More
Atlizumab shows efficacy in the treatment of systemic-onset juvenile idiopathic arthritis
Read More
